Literature DB >> 23637310

Cocaine-evoked synaptic plasticity of excitatory transmission in the ventral tegmental area.

Christian Lüscher1.   

Abstract

Cocaine leads to a strong euphoria, which is at the origin of its recreational use. Past the acute effects, the drug leaves traces in the brain that persist long after it has been cleared from the body. These traces eventually shape behavior such that drug use may become compulsive and addiction develops. Here we discuss cocaine-evoked synaptic plasticity of glutamatergic transmission onto dopamine (DA) neurons of the ventral tegmental area (VTA) as one of the earliest traces after a first injection of cocaine. We review the literature that has examined the induction requirements as well as the expression mechanism of this form of plasticity and ask the question about its functional significance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637310      PMCID: PMC3633178          DOI: 10.1101/cshperspect.a012013

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  50 in total

Review 1.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 2.  Addiction: a disease of learning and memory.

Authors:  Steven E Hyman
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

Review 3.  Synaptic plasticity and addiction.

Authors:  Julie A Kauer; Robert C Malenka
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

4.  Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area.

Authors:  Manuel Mameli; Bénédicte Balland; Rafael Luján; Christian Lüscher
Journal:  Science       Date:  2007-07-27       Impact factor: 47.728

5.  Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system.

Authors:  Stephan Lammel; Andrea Hetzel; Olga Häckel; Ian Jones; Birgit Liss; Jochen Roeper
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

Review 6.  Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death.

Authors:  Siqiong June Liu; R Suzanne Zukin
Journal:  Trends Neurosci       Date:  2007-02-01       Impact factor: 13.837

Review 7.  Molecular basis of NMDA receptor functional diversity.

Authors:  Pierre Paoletti
Journal:  Eur J Neurosci       Date:  2011-03-14       Impact factor: 3.386

8.  Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors.

Authors:  Björn Schilström; Rami Yaka; Emanuela Argilli; Neesha Suvarna; Johanna Schumann; Billy T Chen; Melissa Carman; Vineeta Singh; William S Mailliard; Dorit Ron; Antonello Bonci
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

9.  Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA.

Authors:  Billy T Chen; M Scott Bowers; Miquel Martin; F Woodward Hopf; Anitra M Guillory; Regina M Carelli; Jonathan K Chou; Antonello Bonci
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

Review 10.  The mechanistic classification of addictive drugs.

Authors:  Christian Lüscher; Mark A Ungless
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  16 in total

Review 1.  Synaptic mechanisms underlying persistent cocaine craving.

Authors:  Marina E Wolf
Journal:  Nat Rev Neurosci       Date:  2016-05-06       Impact factor: 34.870

Review 2.  Illicit dopamine transients: reconciling actions of abused drugs.

Authors:  Dan P Covey; Mitchell F Roitman; Paul A Garris
Journal:  Trends Neurosci       Date:  2014-03-20       Impact factor: 13.837

3.  Acute cocaine exposure occludes long-term depression in ventral tegmental area GABA neurons.

Authors:  Lindsey N Friend; Bridget Wu; Jeffrey G Edwards
Journal:  Neurochem Int       Date:  2021-02-20       Impact factor: 3.921

4.  Calcium-permeable AMPA receptor activity and GluA1 trafficking in the basolateral amygdala regulate operant alcohol self-administration.

Authors:  Sara Faccidomo; Elizabeth S Cogan; Olivia J Hon; Jessica L Hoffman; Briana L Saunders; Vallari R Eastman; Michelle Kim; Seth M Taylor; Zoe A McElligott; Clyde W Hodge
Journal:  Addict Biol       Date:  2021-05-05       Impact factor: 4.093

5.  Single Exposure to Cocaine Impairs Reinforcement Learning by Potentiating the Activity of Neurons in the Direct Striatal Pathway in Mice.

Authors:  Zhijun Diao; Yuanyuan Di; Meilin Wu; Chenyang Zhai; Mengsi Kang; Yongfeng Li; Yingxun Liu; Chunling Wei; Qiaohua Zheng; Jing Han; Zhiqiang Liu; Yingfang Tian; Wei Ren
Journal:  Neurosci Bull       Date:  2021-04-27       Impact factor: 5.271

Review 6.  It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.

Authors:  Elena H Chartoff; Hilary S Connery
Journal:  Front Pharmacol       Date:  2014-05-27       Impact factor: 5.810

Review 7.  Ventral Tegmental Area Afferents and Drug-Dependent Behaviors.

Authors:  Idaira Oliva; Matthew J Wanat
Journal:  Front Psychiatry       Date:  2016-03-07       Impact factor: 4.157

8.  Differential Expression of FosB Proteins and Potential Target Genes in Select Brain Regions of Addiction and Depression Patients.

Authors:  Paula A Gajewski; Gustavo Turecki; Alfred J Robison
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

Review 9.  Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure.

Authors:  Barbara Juarez; Ming-Hu Han
Journal:  Neuropsychopharmacology       Date:  2016-03-03       Impact factor: 7.853

10.  Translational control by eIF2α phosphorylation regulates vulnerability to the synaptic and behavioral effects of cocaine.

Authors:  Wei Huang; Andon N Placzek; Gonzalo Viana Di Prisco; Sanjeev Khatiwada; Carmela Sidrauski; Krešimir Krnjević; Peter Walter; John A Dani; Mauro Costa-Mattioli
Journal:  Elife       Date:  2016-03-01       Impact factor: 8.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.